Cargando…

Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?

OBJECTIVE: The aim of the present retrospective population-based study was to investigate the oncologic impact of uterine and ovarian preservation (OP) in premenopausal women with stage IA or IC ovarian clear cell carcinoma (OCCC). METHODS: The National Cancer Institute's Surveillance, Epidemio...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasioudis, Dimitrios, Chapman-Davis, Eloise, Frey, Melissa K., Witkin, Steven S., Holcomb, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641522/
https://www.ncbi.nlm.nih.gov/pubmed/28758377
http://dx.doi.org/10.3802/jgo.2017.28.e71
_version_ 1783271238688309248
author Nasioudis, Dimitrios
Chapman-Davis, Eloise
Frey, Melissa K.
Witkin, Steven S.
Holcomb, Kevin
author_facet Nasioudis, Dimitrios
Chapman-Davis, Eloise
Frey, Melissa K.
Witkin, Steven S.
Holcomb, Kevin
author_sort Nasioudis, Dimitrios
collection PubMed
description OBJECTIVE: The aim of the present retrospective population-based study was to investigate the oncologic impact of uterine and ovarian preservation (OP) in premenopausal women with stage IA or IC ovarian clear cell carcinoma (OCCC). METHODS: The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database was accessed and a cohort of surgically-staged premenopausal women (age <50 years) diagnosed with unilateral stage IA or IC OCCC was drawn. Based on site-specific surgery codes, women who did not undergo hysterectomy and/or bilateral salpingo-oophorectomy (BSO) were identified. Overall survival (OS) and cancer-specific survival (CSS) rates were calculated following generation of Kaplan-Meier curves; comparisons were made with the log-rank test. Multivariate Cox analysis was performed to control for possible confounders. RESULTS: A total of 741 premenopausal women who met the inclusion criteria were identified. Based on available information, rate of uterine preservation was 14.5% (96/663) while the rate of OP was 28.1% (71/253). Five-year CSS rates were 90.8% for women who did not undergo hysterectomy compared with 87.7% for those who did (p=0.290). Similarly, 5-year CSS rates in the OP and BSO groups were 92.6% and 85%, respectively (p=0.060). After controlling for disease sub-stage (IA vs. IC), uterine or OP was not associated with a worse overall or cancer-specific mortality. CONCLUSION: In the present cohort, uterine and OP did not have a negative impact on oncologic outcomes. Selection criteria for fertility-sparing surgery (FSS) could be expanded to include women with stage IA OCCC.
format Online
Article
Text
id pubmed-5641522
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
record_format MEDLINE/PubMed
spelling pubmed-56415222017-11-01 Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma? Nasioudis, Dimitrios Chapman-Davis, Eloise Frey, Melissa K. Witkin, Steven S. Holcomb, Kevin J Gynecol Oncol Original Article OBJECTIVE: The aim of the present retrospective population-based study was to investigate the oncologic impact of uterine and ovarian preservation (OP) in premenopausal women with stage IA or IC ovarian clear cell carcinoma (OCCC). METHODS: The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database was accessed and a cohort of surgically-staged premenopausal women (age <50 years) diagnosed with unilateral stage IA or IC OCCC was drawn. Based on site-specific surgery codes, women who did not undergo hysterectomy and/or bilateral salpingo-oophorectomy (BSO) were identified. Overall survival (OS) and cancer-specific survival (CSS) rates were calculated following generation of Kaplan-Meier curves; comparisons were made with the log-rank test. Multivariate Cox analysis was performed to control for possible confounders. RESULTS: A total of 741 premenopausal women who met the inclusion criteria were identified. Based on available information, rate of uterine preservation was 14.5% (96/663) while the rate of OP was 28.1% (71/253). Five-year CSS rates were 90.8% for women who did not undergo hysterectomy compared with 87.7% for those who did (p=0.290). Similarly, 5-year CSS rates in the OP and BSO groups were 92.6% and 85%, respectively (p=0.060). After controlling for disease sub-stage (IA vs. IC), uterine or OP was not associated with a worse overall or cancer-specific mortality. CONCLUSION: In the present cohort, uterine and OP did not have a negative impact on oncologic outcomes. Selection criteria for fertility-sparing surgery (FSS) could be expanded to include women with stage IA OCCC. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2017-11 2017-07-03 /pmc/articles/PMC5641522/ /pubmed/28758377 http://dx.doi.org/10.3802/jgo.2017.28.e71 Text en Copyright © 2017. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Nasioudis, Dimitrios
Chapman-Davis, Eloise
Frey, Melissa K.
Witkin, Steven S.
Holcomb, Kevin
Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
title Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
title_full Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
title_fullStr Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
title_full_unstemmed Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
title_short Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
title_sort could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641522/
https://www.ncbi.nlm.nih.gov/pubmed/28758377
http://dx.doi.org/10.3802/jgo.2017.28.e71
work_keys_str_mv AT nasioudisdimitrios couldfertilitysparingsurgerybeconsideredforwomenwithearlystageovarianclearcellcarcinoma
AT chapmandaviseloise couldfertilitysparingsurgerybeconsideredforwomenwithearlystageovarianclearcellcarcinoma
AT freymelissak couldfertilitysparingsurgerybeconsideredforwomenwithearlystageovarianclearcellcarcinoma
AT witkinstevens couldfertilitysparingsurgerybeconsideredforwomenwithearlystageovarianclearcellcarcinoma
AT holcombkevin couldfertilitysparingsurgerybeconsideredforwomenwithearlystageovarianclearcellcarcinoma